The global market for cancer therapies is expected to touch around $157.9 million by the end of 2013.
Online PR News – 13-November-2013 – Las Vegas, NV – OXiGENE, Inc. (NASDAQ:OXGN) I have a great stock that you should observe that goes by the name of OXiGENE, Inc. stock symbol OXGN. OXiGENE, Inc. specializes in developing novel therapeutics for the purpose of cancer treatment. The global market for cancer therapies is expected to touch around $157.9 million by the end of 2013. OXiGENE, Inc. presently is experiencing a +26.21% surge Up 0.81 with over 1.5 million shares in play at a price per share value of $3.90 November Tuesday 12, 2013 2:08PM EST. So what's pushing the stock up you ask? I would presume ZYBRESTAT. OXiGENE, Inc. (www.oxigene.com) created ZYBRESTAT for the purpose of potentially treating patients with advanced ovarian cancer. Read article and disclaimer at http://stock-pr.com/23088/stock-alerts/oxigene-stock-surges-on-zybrestat-anticipation-nasdaqoxgn/ Remember: Always do your homework and consult your own financial professional. Read Full Disclaimer at http://stock-pr.com/disclaimer/